Nebraska

LINCOLN, Neb. (July 19, 2018) – Today, a Nebraska law went into effect that allows terminally ill patients to bypass some Food and Drug Administration (FDA) rules that deny access to experimental treatments. Sen. Bob Hilkemann (R-Omaha) introduced Legislature Bill 117 (LB117) last year and it carried over into the 2018 session. The new law…